Webinar Articles
Loading...
From AI to Impact: How GPT Applications are Accelerating Drug Discovery [Webinar]
Causaly cofounders Yiannis Kiachopoulos and Artur Saudabayev hosted a webinar, “From AI to Impact”, in April 2023, exploring the transformative power of AI and GPT applications in early drug discovery. During this captivating session, they demonstrated how Causaly combines visual evidence with high precision knowledge graphs to answer complex research questions in mechanistic biology.
Loading...
Webinar – Knowledge discovery reimagined: finding new hypotheses with Causaly Cloud
Being able to stay up to date with scientific data and efficiently extracting insights is critical to drug R&D – but currently it is a manual, time-consuming process
Loading...
Watch Causaly’s panel discussion from Discovery Europe
On June 9th – 10th 2022, over 400 pharma leaders came to Berlin to take part in Discovery Europe.
Loading...
Roche and Causaly Webinar: AI for smarter portfolio management
Pharmaceutical research is inherently risky and failed or discontinued projects are an inevitable part of the R&D process. A key challenge is that competitive information and the biological validation necessary to decide on target selection and clinical development is often unavailable in a timely or holistic manner.
Loading...
Leveraging AI in early stage drug discovery and due diligence: Autobahn Labs & Causaly webinar
Causaly and Autobahn Labs – an early stage drug discovery incubator launched by Evotec, Samsara Biocapital and KCK – co-hosted a joint webinar on the 29th of June
